| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |